Why Amazon Pulls Supplement Listings: The 5 Compliance Gaps Most Sellers Miss

Most sellers find out the hard way. One morning, the listing is gone — no advance warning, just a suppressed ASIN and a policy violation notice sitting in Seller Central. For supplement brands, this scenario plays out thousands of times a year, and in most cases the underlying problem was entirely preventable.

Amazon’s dietary supplement category is one of the most aggressively policed on the platform. The company’s automated compliance systems and manual review teams can pull a listing within hours of flagging a potential issue. Unlike a pricing violation, a supplement compliance failure can escalate to a permanent account suspension if the brand’s response doesn’t directly address the root cause — with documentation to back it up.

Having worked with supplement sellers ranging from solo formulators to mid-size contract manufacturers, we see the same compliance gaps surface again and again. Here are the five that account for the majority of listing removals we help brands recover from.

1. COAs That Don’t Come From ISO 17025 Accredited Labs

Amazon’s supplement policy is unambiguous: test results submitted in response to a compliance inquiry must come from a laboratory with ISO/IEC 17025 accreditation. A COA from a non-accredited lab — even one with detailed formatting and professional letterhead — will be rejected.

ISO 17025 is the international competency standard for testing and calibration laboratories. Achieving accreditation means a lab has been independently audited, typically by A2LA (American Association for Laboratory Accreditation) or Perry Johnson Laboratory Accreditation (PJLA), to verify that its testing methods are validated, its equipment is calibrated, and its results are technically reproducible. It’s not a certification a lab can self-declare.

The gap we see most often: brands submit COAs generated by their contract manufacturer’s in-house quality control department. Those facilities are almost never ISO 17025 accredited — they run pass/fail checks for production purposes, not independent analytical testing. When Amazon requests substantiation, the manufacturer-issued paperwork gets rejected and the listing stays suppressed.

A COA from an accredited lab should include the lab’s accreditation number and scope, specific method references (USP, AOAC, EPA, or equivalent), quantitative results with measurement uncertainty, and analyst signatures. If yours doesn’t have all of those elements, it won’t hold up under review.

2. Label Claims That Cross the Drug Line

This one surprises sellers more than any other. Amazon’s systems actively scan listing content — titles, bullet points, A+ pages, product descriptions — for language that implies a drug effect. Under FDA’s regulatory framework, any substance that claims to treat, cure, mitigate, or prevent a specific disease is classified as a drug, regardless of how it’s packaged or marketed.

The line between a permissible structure/function claim and a disease claim is narrower than most brands realize. “Supports healthy blood sugar levels” is generally acceptable under DSHEA and 21 CFR 101.93. “Lowers blood glucose in diabetics” is a disease claim that will get a listing removed. “Promotes joint comfort” is fine. “Treats arthritis” is not.

FDA publishes warning letters for exactly this kind of language — they’re searchable at fda.gov/inspections-compliance-enforcement — and Amazon cross-references that enforcement activity when reviewing listings. If your brand or a competitor in the same ingredient category has recently received a warning letter, your listing is more likely to draw scrutiny.

The fix isn’t just editing the listing copy. The product itself needs to be formulated and tested in a way that’s consistent with whatever claim you’re making. We’ve run potency assays on products whose measured active levels didn’t support even the toned-down structure/function claim the brand had switched to after a suspension. That’s a compounding problem.

3. Restricted or Undisclosed Ingredients

Amazon maintains an internal list of prohibited and restricted supplement ingredients. Some are globally flagged substances: SARMs (selective androgen receptor modulators), DMAA (1,3-dimethylamylamine), various synthetic stimulants subject to FDA import alerts, and anything appearing on the agency’s tainted supplement database. Others are ingredients that are technically legal under DSHEA but require specific substantiation before Amazon will approve a listing.

The problem isn’t always intentional misrepresentation. Raw material suppliers — particularly overseas sources for botanical extracts — sometimes use trade names or proprietary blend designations that obscure what’s actually in the material. We’ve encountered botanical ingredients containing pharmaceutical adulterants at concentrations below 10 parts per million: small enough to pass routine QC screening, large enough to trigger a positive result on a more sensitive assay or an FDA compliance test.

Identity testing using HPTLC (High-Performance Thin-Layer Chromatography) or LC-MS/MS (Liquid Chromatography–Mass Spectrometry) can detect adulterants in botanical raw materials before they make it into a finished product. The time to run that test is at incoming receipt from your supplier — not after Amazon flags the listing.

4. Insufficient Purity Data for Heavy Metals and Microbials

Amazon increasingly requires purity testing results alongside potency documentation. That means quantitative data for arsenic, cadmium, lead, and mercury — the four heavy metals covered under USP <2232> for dietary supplements — plus microbial limits results including total aerobic count, yeast and mold, E. coli, and Salmonella.

For brands selling in California, the bar is stricter still. Proposition 65 requires cancer or reproductive toxicity warnings when a product delivers lead above 0.5 micrograms per daily serving or cadmium above 4.1 micrograms per daily serving. These thresholds apply to the finished product serving as consumed, not to the raw material in isolation.

That distinction creates a real problem for multi-botanical formulas. A 3-gram serving of a greens blend can accumulate meaningful lead from six or seven botanical sources even when each individual ingredient tests clean at the raw material level. Finished product heavy metals testing isn’t a redundant step — it’s the only way to know what a consumer is actually ingesting.

Many of the compliance holds we help brands resolve come down to a COA showing heavy metal results for a raw material lot, not the finished product batch. Amazon reviewers know the difference, and so do California’s Prop 65 private enforcers.

5. Complaint Volume That Triggers Algorithmic Review

Even brands with solid documentation get caught by this one. Amazon’s listing quality systems monitor customer review patterns, return rates, and direct product complaints. A cluster of reports alleging adverse effects — unusual reactions, illness, or any suggestion the product may be mislabeled — can trigger an automatic compliance hold, even without a confirmed safety issue.

The defense here isn’t just good manufacturing. It’s documentation speed. When Amazon issues a complaint-triggered review request, brands that can produce a complete compliance file within 48 to 72 hours — a current COA, a GMP audit certificate, a label review summary, and a corrective action narrative — typically resolve the hold in days. Brands that go hunting for documentation after the fact routinely take 2 to 4 weeks, and in several cases we’ve seen, that delay converts a temporary hold into a permanent suspension.

Amazon expects compliance documentation to be maintained on a rolling basis. COAs should be refreshed at minimum every 12 months for stable products, and more frequently for anything with a reformulated ingredient deck or a new raw material supplier on record.

What a Compliant Testing Program Actually Looks Like

Working backwards from Amazon’s requirements, a defensible compliance program for a dietary supplement covers six things:

• Raw material identity testing at the lot level using HPTLC, DNA barcoding, or LC-MS/MS — especially for botanical and proprietary blend ingredients
• Finished product potency testing against label claims, conducted by an ISO 17025 accredited third-party laboratory
• Heavy metals panel on finished product, using USP <2232> limits or California Prop 65 thresholds, whichever are stricter for your primary market
• Microbial limits testing covering total aerobic count, yeast and mold, E. coli, and Salmonella
• Pesticide residue screening for botanical products, per USP <561> or equivalent
• Annual COA refresh to maintain current documentation for each active listing

The upfront cost varies by product complexity — a single-ingredient capsule runs considerably less than a 30-ingredient botanical liquid — but the revenue math is straightforward. A mid-tier Amazon supplement listing generating $50,000 to $80,000 per month can sit suppressed for three to four weeks during a compliance review. Testing costs are a rounding error by comparison.

Don’t wait for Amazon to request documentation. Build the compliance file before the listing goes live, review it annually, and store it somewhere your full team can access within minutes. That preparation is what separates brands that resolve holds in days from those that lose the listing entirely.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• FDA Audit Preparation and 21 CFR Compliance Consulting — Aurora TIC helps supplement and device companies prepare for FDA inspections and build defensible compliance programs before regulators come knocking.
• Raw Material Identity Testing and Supplier Qualification — Ayah Labs supports global ingredient buyers with independent raw material testing, COA verification, and supplier qualification programs.